Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells

被引:139
作者
Cheung, JYN
Ong, RCY
Suen, YK
Ooi, V
Wong, HNC
Mak, TCW
Fung, KP
Yu, B
Kong, SK [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod, Shanghai 200032, Peoples R China
关键词
polyphyllin D; apoptosis; drug resistance; HepG2;
D O I
10.1016/j.canlet.2004.06.042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a search for new anticancer agents, we identified a novel compound polyphyllin D (PD) (diosgenyl alpha-L-rhamnopyranosyl(1-->2)-(alpha-L-arabinofuranosyl)-(1-->4)]-[beta-D-glucopyranoside) that induced DNA fragmentation and phosphatidyl-serine (PS) externalization in a hepatocellular carcinoma cell line HepG2 derivative with drug resistance (R-HepG2). PD is a saponin originally found in a tradition Chinese medicinal herb Paris polyphylla. It has been used to treat liver cancer in China for many years. We evaluated the cell-killing mechanisms of this compound in R-HepG2 and its parental cells. The mitochondrial apoptotic pathway was found to be involved in the PD-induced apoptosis because PD elicited depolarization of mitochondrial transmembrane potential (DeltaPsim), generation of H2O2, as well as release of cytochrome c and apoptosis-inducing factor in a dose- and time-dependent manner. In conclusion, we show for the first time that PD is a potent anticancer agent that can overcome drug resistance in R-HepG2 cells and elicit programmed cell death via mitochondrial dysfunction. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 19 条
[1]   THE ANTIOXIDANT ACTION OF N-ACETYLCYSTEINE - ITS REACTION WITH HYDROGEN-PEROXIDE, HYDROXYL RADICAL, SUPEROXIDE, AND HYPOCHLOROUS ACID [J].
ARUOMA, OI ;
HALLIWELL, B ;
HOEY, BM ;
BUTLER, J .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 6 (06) :593-597
[2]   THE ROLE OF DNA FRAGMENTATION IN APOPTOSIS [J].
BORTNER, CD ;
OLDENBURG, NBE ;
CIDLOWSKI, JA .
TRENDS IN CELL BIOLOGY, 1995, 5 (01) :21-26
[3]   Apoptosis-inducing factor (AIF):: key to the conserved caspase-independent pathways of cell death? [J].
Candé, C ;
Cecconi, F ;
Dessen, P ;
Kroemer, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (24) :4727-4734
[4]   Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA [J].
Chan, JYW ;
Chu, ACY ;
Fung, KP .
LIFE SCIENCES, 2000, 67 (17) :2117-2124
[5]   A NEW METHOD FOR THE CYTOFLUOROMETRIC ANALYSIS OF MITOCHONDRIAL-MEMBRANE POTENTIAL USING THE J-AGGREGATE FORMING LIPOPHILIC CATION 5,5',6,6'-TETRACHLORO-1,1',3,3'-TETRAETHYLBENZIMIDAZOLCARBOCYANINE IODIDE (JC-1) [J].
COSSARIZZA, A ;
BACCARANICONTRI, M ;
KALASHNIKOVA, G ;
FRANCESCHI, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (01) :40-45
[6]   Mitochondrion as a novel target of anticancer chemotherapy [J].
Costantini, P ;
Jacotot, E ;
Decaudin, D ;
Kroemer, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13) :1042-1053
[7]   Synthesis of three diosgenyl saponins: dioscin, polyphyllin D, and balanitin 7 [J].
Deng, SJ ;
Yu, B ;
Hui, YZ ;
Yu, H ;
Han, XW .
CARBOHYDRATE RESEARCH, 1999, 317 (1-4) :53-62
[8]   APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD [J].
FISHER, DE .
CELL, 1994, 78 (04) :539-542
[9]   Mechanisms of cancer drug resistance [J].
Gottesman, MM .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627
[10]  
Henry SH, 2002, ADV EXP MED BIOL, V504, P229